alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM GULFWEST
OIL COMPANY'S QUARTERLY REPORT FILED ON FORM 10-Q FOR THE QUARTER ENDED JUNE
30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
DOCUMENTS.
</LEGEND>
<CIK>                         0000813779
<NAME>                        0
<MULTIPLIER>                  1
<CURRENCY>                    0

<S>                          <C>
<PERIOD-TYPE>                 6-MOS
<FISCAL-YEAR-END>             DEC-31-1999
<PERIOD-START>                JAN-01-2000
<PERIOD-END>                  JUN-30-2000
<EXCHANGE-RATE>               1
<CASH>                        305,508
<SECURITIES>                  0
<RECEIVABLES>                 1,745,739
<ALLOWANCES>                  0
<INVENTORY>                   0
<CURRENT-ASSETS>              2,101,217
<PP&E>                        26,664,222
<DEPRECIATION>                3,301,955
<TOTAL-ASSETS>                26,090,816
<CURRENT-LIABILITIES>         6,550,763
<BONDS>                       0
<PREFERRED-MANDATORY>         0
<PREFERRED>                   80
<COMMON>                      17,885
<OTHER-SE>                    5,838,388
<TOTAL-LIABILITY-AND-EQUITY>  26,090,816
<SALES>                       1,930,127
<TOTAL-REVENUES>              2,124,077
<CGS>                         0
<TOTAL-COSTS>                 1,519,783
<OTHER-EXPENSES>              0
<LOSS-PROVISION>              0
<INTEREST-EXPENSE>            538,855
<INCOME-PRETAX>               82,186
<INCOME-TAX>                  0
<INCOME-CONTINUING>           82,186
<DISCONTINUED>                0
<EXTRAORDINARY>               0
<CHANGES>                     0
<NET-INCOME>                  82,186
<EPS-BASIC>                   0
<EPS-DILUTED>                 0



</TABLE>
§ 522.1335 Medetomidine. ( a ) *Specifications.* Each milliliter of solution contains 1.0 milligrams of medetomidine hydrochloride.
( b ) *Sponsor.* See Nos. 015914 and 052483 in § 510.600(c) of this chapter.
( c ) *Conditions of use* — ( 1 ) *Amount.* 750 micrograms intravenously (IV) or 1,000 micrograms intramuscularly per square meter of body surface. The IV route is more efficacious for dental care.
( 2 ) *Indications for use.* As a sedative and analgesic in dogs over 12 weeks of age to facilitate clinical examinations, clinical procedures, minor surgical procedures not requiring muscle relaxation, and minor dental procedures not requiring intubation. The intravenous route of administration is more efficacious for dental care.
( 3 ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[61 FR 21075, May 9, 1996, as amended at 79 FR 16191, Mar. 25, 2014; 82 FR 58556, Dec. 13, 2017]
EXHIBIT 32

                   CERTIFICATION OF PERIODIC FINANCIAL REPORT
                       PURSUANT TO 18 U.S.C. SECTION 1350

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, each of the undersigned officers of AMCOL
International Corporation (the "Company") certifies that the quarterly report on
Form 10-Q of the Company for the three months ended March 31, 2005 fully
complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 and information contained in that Form 10-Q fairly
presents, in all material respects, the financial condition and results of
operations of the Company.

Date: May 10, 2005                             /s/ Lawrence E. Washow
                                               --------------------------------
                                               Lawrence E. Washow
                                               Chief Executive Officer


Date: May 10, 2005                             /s/ Gary L. Castagna
                                               --------------------------------
                                               Gary L. Castagna
                                               Chief Financial Officer
§ 522.2473 Tiludronate. ( a ) *Specifications.* Each vial of powder contains 500 milligrams (mg) tiludronate disodium. Each milliliter of constituted solution contains 20 mg tiludronate disodium.
( b ) *Sponsor.* See No. 061133 in § 510.600(c) of this chapter.
( c ) *Conditions of use in horses* — ( 1 ) *Amount.* Administer a single dose of 1 mg per kilogram (0.45 mg/pound) of body weight by intravenous infusion.
( 2 ) *Indication for use.* For the control of clinical signs associated with navicular syndrome.
( 3 ) *Limitations.* Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[79 FR 18159, Apr. 1, 2014, as amended at 82 FR 21691, May 10, 2017; 84 FR 8974, Mar. 13, 2019]
<PAGE>

                                                                    Exhibit 32.1

                                 PROTHERICS PLC

         CERTIFICATIONS PURSUANT TO RULE 13a-14(b) OF THE SECURITIES ACT
       OF 1934, AS AMENDED, AND 18 U.S.C. Section 1350, AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection with the Report of Protherics PLC (the "Company") on Form
20-F for the year ended March 31, 2005, as filed with the Securities and
Exchange Commission (the "SEC") on the date hereof (the "Report"), Andrew J.
Heath, Chief Executive Officer of the Company, and Barrington M. Riley, Chief
Financial Officer of the Company, certify, pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63
of Title 18, United States Code) that:

      (1)   The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934 (the "Exchange Act"); and

      (2)   Information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

Date: July 22, 2005                            /s/ Andrew J. Heath
                                               ---------------------------------
                                               Andrew J. Heath
                                               Chief Executive Officer

                                               /s/ Barrington M. Riley
                                               ---------------------------------
                                               Barrington M. Riley
                                               Chief Financial Officer
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          39,260
<SECURITIES>                                    64,167
<RECEIVABLES>                                   79,242
<ALLOWANCES>                                    10,752
<INVENTORY>                                          0
<CURRENT-ASSETS>                               134,654
<PP&E>                                         227,295
<DEPRECIATION>                                  92,171
<TOTAL-ASSETS>                                 501,364
<CURRENT-LIABILITIES>                           70,812
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           784
<OTHER-SE>                                     142,305
<TOTAL-LIABILITY-AND-EQUITY>                   501,364
<SALES>                                              0
<TOTAL-REVENUES>                               248,359
<CGS>                                                0
<TOTAL-COSTS>                                  157,754
<OTHER-EXPENSES>                                18,487
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               8,045
<INCOME-PRETAX>                                 67,471
<INCOME-TAX>                                    27,326
<INCOME-CONTINUING>                             40,145
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    40,145
<EPS-BASIC>                                        .84
<EPS-DILUTED>                                      .81



</TABLE>
§ 133.121 Low sodium colby cheese. Low sodium colby cheese is the food prepared from the same ingredients and in the same manner prescribed in § 133.118 for colby cheese and complies with all the provisions of § 133.118, including the requirements for label statement of ingredients, except that: ( a ) Salt is not used. Any safe and suitable ingredient or combination of ingredients that contains no sodium and that is recognized as a salt substitute may be used.
( b ) Sodium sorbate is not used.
( c ) It contains not more than 96 milligrams of sodium per pound of finished food.
( d ) The name of the food is “low sodium colby cheese”. The letters in the words “low sodium” shall be of the same size and style of type as the letters in the words “colby cheese”, wherever such words appear on the label.
( e ) If a salt substitute as provided for in paragraph (a) of this section is used, the label shall bear the statement “______ added as a salt substitute”, the blank being filled in with the common name or names of the ingredient or ingredients used as a salt substitute.
[42 FR 14366, Mar. 15, 1977, as amended at 58 FR 2892, Jan. 6, 1993; 85 FR 72907, Nov. 16, 2020]
Exhibit 32.1


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Annual Report of Astea International Inc. (the "Company")
on Form 10-K for the period ending December 31, 2004 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Zack
Bergreen, Chief Executive Officer and Principal Executive Officer of the
Company, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906
of the Sarbanes-Oxley Act of 2002, that:

         (1)      The Report fully complies with the requirements of section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      The information contained in the Report fairly presents, in
                  all material respects, the financial condition and results of
                  operations of the Company.




                                               /s/Zack Bergreen
                                               ----------------
                                               Zack Bergreen
                                               Chief Executive Officer
                                               (Principal Executive Officer)
                                               March 28, 2005





<PAGE>
TS-EMLA50/60/70/80

Attachment #6

Pt. 2, Sec. A, 3 

Environmental Release and Disposal Information on the New Chemical Substance at 

Industrial Sites Controlled by the Submitter – Manufacture and Processing
[Federal Register Volume 75, Number 37 (Thursday, February 25, 2010)]
[Presidential Documents]
[Page 8793]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4107]



[[Page 8791]]

-----------------------------------------------------------------------

Part II





The President





-----------------------------------------------------------------------



Notice of February 23, 2010--Continuation of the National Emergency 
Relating to Cuba and of the Emergency Authority Relating to the 
Regulation of the Anchorage and Movement of Vessels


                        Presidential Documents 



Federal Register / Vol. 75, No. 37 / Thursday, February 25, 2010 / 
Presidential Documents

___________________________________________________________________

Title 3--
The President

[[Page 8793]]

                Notice of February 23, 2010

                
Continuation of the National Emergency Relating 
                to Cuba and of the Emergency Authority Relating to the 
                Regulation of the Anchorage and Movement of Vessels

                On March 1, 1996, by Proclamation 6867, a national 
                emergency was declared to address the disturbance or 
                threatened disturbance of international relations 
                caused by the February 24, 1996, destruction by the 
                Cuban government of two unarmed U.S.-registered 
                civilian aircraft in international airspace north of 
                Cuba. On February 26, 2004, by Proclamation 7757, the 
                national emergency was extended and its scope was 
                expanded to deny monetary and material support to the 
                Cuban government. The Cuban government has not 
                demonstrated that it will refrain from the use of 
                excessive force against U.S. vessels or aircraft that 
                may engage in memorial activities or peaceful protest 
                north of Cuba. And the unauthorized entry of any U.S.-
                registered vessel into Cuban territorial waters 
                continues to be detrimental to the foreign policy of 
                the United States. Therefore, in accordance with 
                section 202(d) of the National Emergencies Act (50 
                U.S.C. 1622(d)), I am continuing the national emergency 
                with respect to Cuba and the emergency authority 
                relating to the regulation of the anchorage and 
                movement of vessels set out in Proclamation 6867 as 
                amended by Proclamation 7757.

                This notice shall be published in the Federal Register 
                and transmitted to the Congress.
                <GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT>
                
                    (Presidential Sig.)

                THE WHITE HOUSE,

                    February 23, 2010.

[FR Doc. 2010-4107
Filed 2-24-10; 11:15 am]
Billing code 3195-W0-P
<PAGE>


                                                                 EXHIBIT 10.16.7

                                    WESTCORP

              EMPLOYEE STOCK OWNERSHIP PLAN AND SALARY SAVINGS PLAN

            (As Amended and Restated Effective as of January 1, 2001)

                               AMENDMENT NO. SEVEN

      WHEREAS, WESTCORP, a California corporation (the "Company") established
the Westcorp Employee Stock Ownership Plan and Salary Savings Plan (the "Plan"),
effective as of January 1, 1975, for the benefit of its eligible employees and
their beneficiaries; and

      WHEREAS, the Company adopted the 2001 Restatement of the Plan effective as
of January 1, 2001 and the Plan was amended thereafter on six separate
occasions; and

      WHEREAS, Section 17.1 of the Plan gives the Administrative Committee of
the Plan the authority to amend the Plan; and

      WHEREAS, the Administrative Committee has determined that it is in the
best interest of the Plan's participants and their beneficiaries that the Plan
be amended as set forth herein.

      NOW, THEREFORE, pursuant to resolutions adopted by the Plan's
Administrative Committee, the Plan is hereby amended effective as of January 1,
2004 as follows:

      Section 2.26 is hereby amended in its entirety to read as follows:

      "2.26 Entry Date. "Entry Date" shall mean the 1st day of each calendar
month."
<PAGE>
IN WITNESS WHEREOF, the Administrative Committee of the Westcorp Employee Stock
Ownership Plan and Salary Savings Plan has adopted this Amendment No. Seven on
the 18th day of December, 2003.

                                   ADMINISTRATIVE COMMITTEE OF THE
                                   WESTCORP EMPLOYEE STOCK OWNERSHIP
                                   PLAN AND SALARY SAVINGS PLAN


                                   By:
                                       -----------------------------------------
                                          Shaunna Monticelli, Chairman
                                          Administrative Committee
                                          Westcorp Employee Stock Ownership Plan
                                          and Salary Savings Plan


                                        2
Electronically Filed

Intermediate Court of Appeals

CAAP-15-0000452

13-OCT-2015

09:27 AM
ATENCIÓN 

Zona de pastoreo de ovejas

Los pastores utilizan perros para dirigir y proteger sus ovejas al ahuyentar depredadores. Aquí se utilizan perros para proteger 

las ovejas. Si usted no aparenta ser una amenaza para las ovejas, muchas veces, los perros solo lo observarán.

Desde: Hasta:

El USDA es un proveedor y empleador que ofrece igualdad de oportunidades. 

Departamento de Agricultura de los Estados Unidos • Servicio de Inspección de Sanidad Agropecuaria 

Programa de asistencia N.o 2053S • Emitido en marzo de 2012

USDA/APHIS

Evite conflictos con perros guardianes. Evite:

4 Caminar o andar en su vehículo todoterreno o su bicicleta de montaña en 

medio del rebaño o cerca de este.

4 Realizar movimientos rápidos o violentos cerca de los perros o las ovejas.

4 Intentar golpear o arrojar cosas a los perros o las ovejas.

4 Gritarle a los perros o las ovejas, salvo que se aproximen; en ese caso, grite 

“atrás” o “¡no!”

4 Tratar de huir de los perros.

Procure:

4 Detenerse y bajarse de su bicicleta de montaña.

4 Colocar la bicicleta entre usted y el perro.

4 Caminar con la bicicleta al lado hasta que finalmente se haya alejado de las 

ovejas.

4 Mantener distancia del rebaño. 

4 Sujetar sus perros con correa en todo momento.

4 Estar atento a los perros guardianes y al pastor.

4 Mantener la calma si los perros se aproximan.

Si tiene preguntas sobre los perros guardianes de ganado u otros asuntos relacionados con el manejo de daños causados 

por la vida silvestre, comuníquese con el Servicio de Vida Silvestre (Wildlife Services, WS), un programa del Servicio de 

Inspección de Sanidad Agropecuaria (Animal and Plant Health Inspection Service, APHIS) del Departamento de Agricultura de los Estados Unidos (U.S.Department of Agriculture, USDA ), al 1-866-4-USDA-WS (1-866-487-3297), o bien 

visite el sitio web de APHIS en www.aphis.usda.gov/wildlife_damage.

Uso de perros guardianes de ganado
<PAGE>

                                                            EXHIBIT 23.1


                       CONSENT OF INDEPENDENT AUDITORS

We consent to the incorporation by reference in the Registration Statement 
(Form S-3 No. 333-02247) of United Stationers Inc. and in the related 
Prospectus of our reports dated June 27, 1995 with respect to the 
consolidated financial statements and schedule of United Stationers Inc. for 
the seven-month period ended March 30, 1995 and January 28, 1996 with respect 
to the consolidated financial statements and schedules of United Stationers 
Inc. as of and for the years ended December 31, 1996 and 1995 included in 
this Annual Report (Form 10-K) for the year ended December 31, 1996.

                                              /s/Ernst & Young LLP



Chicago, Illinois
March 25, 1997
Exhibit 23

Consent of Independent Registered Public Accounting Firm

The
Board of Directors
Ballantyne Strong, Inc.:

We
consent to the incorporation by reference in the registration statements (File Nos. 333-03849, 333-116739, 333-139177, and
333-153408) on Form S-8 of Ballantyne Strong, Inc. (the Company) of our report dated March 23, 2010 with respect to the consolidated balance sheets of Ballantyne
Strong, Inc. and subsidiaries as of December 31, 2009 and 2008, and the related consolidated statements of operations, stockholders' equity and comprehensive income (loss), and cash flows for
each of the years in the three-year period ended December 31, 2009, and the related financial statement schedule II, which report appears in the December 31, 2009 annual report on
Form 10-K of Ballantyne Strong, Inc.

/s/ KPMG
LLP

Omaha,
Nebraska
March 23, 2010

---



QuickLinks
§ 205.8 Violations and penalties. ( a ) State licensing laws shall provide for the suspension or revocation of licenses upon conviction of violations of Federal, State, or local drug laws or regulations, and may provide for fines, imprisonment, or civil penalties.
( b ) State licensing laws shall provide for suspension or revocation of licenses, where appropriate, for violations of its provisions.
§ 520.88e Amoxicillin trihydrate boluses. ( a ) *Specifications.* Each bolus contains amoxicillin trihydrate equivalent to 400 milligrams (mg) amoxicillin.
( b ) *Sponsor.* See No. 054771 in § 510.600(c) of this chapter.
( c ) *Related tolerances.* See § 556.38 of this chapter.
( d ) *Conditions of use in cattle* — ( 1 ) *Amount.* Administer 400 mg per 100 pounds of body weight twice daily. Treatment should be continued for 48 hours after all symptoms have subsided but not to exceed 5 days.
( 2 ) *Indications for use.* Treatment of bacterial enteritis when due to susceptible *Escherichia coli* in preruminating calves including veal calves.
( 3 ) *Limitations.* Do not slaughter animals during treatment or for 20 days after the latest treatment. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[57 FR 37320, Aug. 18, 1992, as amended at 60 FR 55659, Nov. 2, 1995; 62 FR 5526, Feb. 6, 1997; 79 FR 28817, May 20, 2014]
-84 -82 -80 -78 -76 -74

36 38 40 42



### ★

▲ ▲ ▲ ▲



### ★ ▲ ▲ ▲ ▲ 500 1000 1500 500 18 12 06 00 06/21 

### NOAA HYSPLIT MODEL 

## Backward trajectory ending at 2300 UTC 21 Jun 06

EDAS Meteorological DataSource★at 38.92 N 77.01 WMeters AGL
<PAGE>   1
                                 EXHIBIT 23




                         Independent Auditors' Consent




The Board of Directors
MS Financial, Inc.:


We consent to incorporation by reference in the registration statement (No.
33-306373) on Form S-8 of MS Financial, Inc. of our report dated February 24,
1997 relating to the consolidated balance sheets of MS Financial, Inc. and
subsidiary as of December 31, 1995 and 1996, and the related consolidated
statements of operations, stockholders' equity and cash flows for each of the
years in the three-year period ended December 31, 1996, which report appears in
the December 31, 1996 annual report on Form 10-K of MS Financial, Inc.

Our report dated February 24, 1997, contains an explanatory paragraph that
states that MS Financial, Inc.'s material increases in delinquencies and losses
on owned and serviced installment contracts, substantial net loss in 1996 and
reduced availability of financing raise substantial doubt about the entity's
ability to continue as a going concern. The consolidated financial statements
do not include any adjustments that might result from the outcome of that
uncertainty.




                                                     KPMG Peat Marwick LLP

Jackson, Mississippi
March 18, 1997